Analysts Estimate Azenta (AZTA) to Report a Decline in Earnings: What to Look Out for
Brooks (AZTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?
Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.
Azenta (NASDAQ:AZTA) Issues FY 2024 Earnings Guidance
Azenta (NASDAQ:AZTA – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 0.270-0.370 for the period, compared to the consensus estimate of 0.260. The company issued revenue guidance of $659.0 million-$671.0 million, compared to the consensus revenue estimate of $703.8 million. Azenta Stock Performance Shares of NASDAQ:AZTA opened at $50.87 on Monday. The company has a market capitalization of $2.74 billion, a P/E ratio of -18.77 and a beta of 1.51. The company’s 50-day moving average is $55.67 and its 200 day moving average is $59.53. Azenta has a fifty-two week low of $40.41 and a fifty-two week high of $69.16. Azenta (NASDAQ:AZTA – Get Free Report) last announced its quarterly earnings data on Wednesday, May 8th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. The business had revenue of $159.13 million during the quarter, compared to analyst estimates of $159.89 million. Azenta had a positive return on equity of 0.81% and a negative net margin of 23.12%. Azenta’s revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.06) earnings per share. As a group, research analysts predict that Azenta will post 0.29 earnings per share for the current year. Analyst Ratings Changes A number of research analysts have commented on the stock. Stephens reiterated an equal weight rating and set a $70.00 price target on shares of Azenta in a research report on Thursday, February 8th. B. Riley increased their target price on shares of Azenta from $61.00 to $79.00 and gave the company a buy rating in a report on Thursday, February 1st. Evercore ISI lowered their price target on shares of Azenta from $64.00 to $60.00 and set an in-line rating for the company in a research note on Thursday, April 4th. Needham & Company LLC reduced their price objective on Azenta from $75.00 to $69.00 and set a buy rating on the stock in a research note on Thursday, May 9th. Finally, Jefferies Financial Group began coverage on Azenta in a research note on Thursday, April 4th. They issued a hold rating and a $64.00 target price for the company. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Azenta currently has a consensus rating of Hold and a consensus price target of $68.40. Get Our Latest Report on Azenta About Azenta (Get Free Report) Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
